XML 14 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Sales:    
Total net sales $ 3,977,650 $ 3,087,984
Cost of sales:    
Total cost of sales 1,811,847 1,593,268
Gross profit 2,165,803 1,494,716
Operating expenses:    
Research and development 596,372 923,721
Selling, general and administrative 1,473,416 1,622,555
Total operating expenses 2,069,788 2,546,276
Operating income (loss) 96,015 (1,051,560)
Interest income 21,552 9,624
Other income 21,854 21,431
Income (loss) before income taxes 139,421 (1,020,505)
Income tax expense (benefit) 0 (138,886)
Net income (loss) $ 139,421 $ (881,619)
Net income(loss) per common share:    
Basic (in dollars per share) $ 0.01 $ (0.05)
Diluted (in dollars per share) $ 0.01 $ (0.05)
Weighted average shares outstanding:    
Basic (in shares) 16,840,599 16,783,129
Diluted (in shares) 16,840,599 16,783,129
Product    
Sales:    
Total net sales $ 3,775,509 $ 3,087,984
Cost of sales:    
Total cost of sales 1,723,281 $ 1,593,268
Engineering development contracts    
Sales:    
Total net sales 202,141  
Cost of sales:    
Total cost of sales $ 88,566